MB
Mark Benyunes
Medical Oncology
Credentials: ·
Research
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer
New England Journal of Medicine · 2012 · 1,966 citations
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer
New England Journal of Medicine · 2015 · 1,656 citations
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
New England Journal of Medicine · 2017 · 1,100 citations
- JT
16 papers
- WB
6 papers
- AK
5 papers
- JB
5 papers
- SS
5 papers
- CH
4 papers
4 papers
- DK
3 papers
